Elekta wins public tender to deliver advanced cancer care solutions to New Karolinska Solna (NKS)

STOCKHOLM, May 25, 2016 – Stockholm County Council (Sweden), announced today
that Elekta has been awarded the public tender to exclusively equip the
Radiation Therapy Department of its new, flagship hospital, the New Karolinska
Solna (NKS).
Tomas Puusepp, Elekta’s President and CEO, says: “As a Swedish corporation
headquartered in Stockholm, and as a world leader in cancer care, we are
delighted to be awarded this prestigious tender. We are fully committed to
investing in research and innovation and in providing our state-of-the-art
technology in collaboration with NKS, in order to strengthen cancer care in the
Stockholm region. It is exciting to further expand and deepen our collaboration
with Karolinska (NKS), the hospital where stereotactic radiotherapy originated.
Karolinska is a visionary and a great partner to Elekta’s own pioneering spirit
in research, development and clinical advancement to support cancer care
throughout the world.”

The agreement is expected to be formally signed during Elekta’s first fiscal
quarter 2016/17 and the bulk of the installation will occur in April 2017. The
final decision is pending a 10-day review process during which the decision can
be appealed.

# # #

For further information, please contact:
Gert van Santen, Group Vice President Corporate Communications, Elekta AB
Tel: +31 653 561 242, e-mail: gert.vansanten@elekta.com
Time zone: CET: Central European Time

Tobias Bülow, Director Financial Communication, Elekta AB
Tel: +46 722 215 017, e-mail: tobias.bulow@elekta.com
Time zone: CET: Central European Time

The above information is such that Elekta AB (publ) shall make public in
accordance with the Securities Market Act and/or the Financial Instruments
Trading Act. The information was published at 07:30 CET on May 25, 2016.

About Elekta
Elekta is a human care company pioneering significant innovations and clinical
solutions for treating cancer and brain disorders. The company develops
sophisticated, state-of-the-art tools and treatment planning systems for
radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing
software systems across the spectrum of cancer care. Stretching the boundaries
of science and technology, providing intelligent and resource-efficient
solutions that offer confidence to both health care providers and patients,
Elekta aims to improve, prolong and even save patient lives.

Today, Elekta solutions in oncology and neurosurgery are used in over 6,000
hospitals worldwide. Elekta employs around 3,800 employees globally. The
corporate headquarters is located in Stockholm, Sweden, and the company is
listed on NASDAQ Stockholm. Website: www.elekta.com.